Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biondvax Pharma ADR (NQ: BVXV )

N/A UNCHANGED
Last Price Updated: 3:59 PM EDT, Sep 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biondvax Pharma ADR

< Previous 1 2 3 4 5 6 7 8 Next >
New Research Shows Brain Stimulation Improves Reading Ability of Macular Degeneration Patients
Via Investor Brand Network
BioMedNewsBreaks – Aegis Capital Corp. Acted as Sole Bookrunner on BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) $8M Underwritten Public Offering
Via Investor Brand Network
Aegis Capital Corp. Acted as Sole Bookrunner on an $8 Million Underwritten Public Offering for BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV)
Via ACCESSWIRE
Experts Push for More Studies into Link Between Asthma, Female Sex Hormones
Via Investor Brand Network
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Closes $8M Underwritten Public Offering
Via Investor Brand Network
BiondVax Announces Closing of $8 Million Underwritten Public Offering
From BiondVax Pharmaceuticals Ltd.
Via GlobeNewswire
Why Biondvax Pharmaceuticals Stock Is Getting Obliterated During Friday's Trading Session
Biondvax Pharmaceuticals Ltd - ADR (NASDAQ: BVXV) shares are trading lower by 58.60% to $3.64 during Friday's session after the company priced its 1.6 million unit offering at $5 per unit. 
Via Benzinga
Dow Tumbles 400 Points; Maxar Technologies Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 400 points on Friday. 
Via Benzinga
Nasdaq Falls Over 100 Points; Crude Oil Drops Sharply
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 100 points on Friday. 
Via Benzinga
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Pricing on Public Offering, Expects to Raid $8M
Via Investor Brand Network
Dow Drops 200 Points; Accenture Posts Upbeat Results
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Friday. 
Via Benzinga
BiondVax Announces Pricing of $8 Million Underwritten Public Offering
From BiondVax Pharmaceuticals Ltd.
Via GlobeNewswire
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Featured in ‘Stock2Me’ Podcast
Via Investor Brand Network
Exposures COVID-19
Psoriasis Patients Report Being Embarrassed Because of Flare-Ups in Intertriginous Areas
Via Investor Brand Network
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Innovative Inhaled COVID-19 NanoAb Therapy Shows Statistically Significant Efficacy Results in Preclinical Study
Via Investor Brand Network
Exposures COVID-19
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Regains Compliance with Nasdaq Listing Rules
Via Investor Brand Network
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Featured in Investment Research Report
Via Investor Brand Network
Exposures COVID-19
Teens Suffering from Concussions Could Benefit from Screen Time
Via Investor Brand Network
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Names Experienced Researcher as Advisory Board Member
Via Investor Brand Network
Exposures COVID-19
Professor Dr. Matthias Dobbelstein joins BiondVax’s Scientific Advisory Board
From BiondVax Pharmaceuticals Ltd.
Via GlobeNewswire
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Releases Q3 2022 Financial Results, Corporate Updates
Via Investor Brand Network
BiondVax announces Third Quarter 2022 Financial Results and Provides Business Update
From BiondVax Pharmaceuticals Ltd.
Via GlobeNewswire
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Confirms Inhalation Concept of NanoAb as Therapy for COVID-19
Via Investor Brand Network
Exposures COVID-19
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Pipeline Focused on Creating Innovative Immunotherapeutic Products for Treating Underserved Infectious and Autoimmune Diseases
Via Investor Brand Network
Exposures COVID-19
BiondVax reports successful results in preclinical in vivo study of its innovative inhaled COVID-19 NanoAb therapy
From BiondVax Pharmaceuticals Ltd.
Via GlobeNewswire
Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday
Gainers AEye, Inc. (NASDAQ: LIDR) shares jumped 50% to close at $1.25 on Friday. AEye recently posted a Q3 loss of $0.11 per share. 
Via Benzinga
Why Canoo Shares Are Trading Higher By Over 12%? Here Are 32 Stocks Moving In Friday's Mid-Day Session
Gainers Peak Bio, Inc. (NYSE: PKBO) shares jumped 49.1% to $7.08. 
Via Benzinga
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Director of Communications and Investor Relations Presents at LD Micro Main Event
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.